Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2010
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background
Emmanuel Itti, Malik E Juweid, Corinne Haioun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study
Sally F Barrington, Farheen Mir, Tarec Christoffer El-Galaly, et al.
Leukemia & Lymphoma
|
March 7, 2014
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
Julia Chalaye, Alain Luciani, Catalina Enache, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2014
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Michel Meignan, Myriam Sasanelli, René Olivier Casasnovas, et al.
Investigative Radiology
|
January 26, 2011
Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study
Chieh Lin, Emmanuel Itti, Alain Luciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab
Violaine Safar, Jehan Dupuis, Emmanuel Itti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2013
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, et al.
Medicine
|
May 8, 2015
Positron Emission Tomography With 18F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome
Nicolas de Prost, Myriam Sasanelli, Jean-François Deux, et al.
Cancer Immunology, Immunotherapy : CII
|
December 16, 2006
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model
Coralie Chaise, Emmanuel Itti, Yolande Petegnief, et al.
Haematologica
|
June 7, 2007
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma
Jehan Dupuis, Philippe Gaulard, Francois Hemery, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2010
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background
Emmanuel Itti, Malik E Juweid, Corinne Haioun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 3, 2021
Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study
Sally F Barrington, Farheen Mir, Tarec Christoffer El-Galaly, et al.
Leukemia & Lymphoma
|
March 7, 2014
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
Julia Chalaye, Alain Luciani, Catalina Enache, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2014
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Michel Meignan, Myriam Sasanelli, René Olivier Casasnovas, et al.
Investigative Radiology
|
January 26, 2011
Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study
Chieh Lin, Emmanuel Itti, Alain Luciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab
Violaine Safar, Jehan Dupuis, Emmanuel Itti, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2013
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, et al.
Medicine
|
May 8, 2015
Positron Emission Tomography With 18F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome
Nicolas de Prost, Myriam Sasanelli, Jean-François Deux, et al.
Cancer Immunology, Immunotherapy : CII
|
December 16, 2006
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model
Coralie Chaise, Emmanuel Itti, Yolande Petegnief, et al.
Haematologica
|
June 7, 2007
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma
Jehan Dupuis, Philippe Gaulard, Francois Hemery, et al.
Page
of 13